Cargando…
Cytokine Polymorphisms and Susceptibility to Severe Infectious Diseases
Cytokines are key regulators of the host response to infection, controlling the inflammatory reaction which is an essential component of the defense mechanisms. The major importance of these proteins in the pathogenesis and outcome of infectious diseases has been clearly demonstrated. In humans, the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kluwer Academic Publishers
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144473/ https://www.ncbi.nlm.nih.gov/pubmed/32288621 http://dx.doi.org/10.1023/A:1013222407924 |
_version_ | 1783519839023792128 |
---|---|
author | Chiche, Jean-Daniel Siami, Shidasp Dhainaut, Jean-FrançDois Mira, Jean-Paul |
author_facet | Chiche, Jean-Daniel Siami, Shidasp Dhainaut, Jean-FrançDois Mira, Jean-Paul |
author_sort | Chiche, Jean-Daniel |
collection | PubMed |
description | Cytokines are key regulators of the host response to infection, controlling the inflammatory reaction which is an essential component of the defense mechanisms. The major importance of these proteins in the pathogenesis and outcome of infectious diseases has been clearly demonstrated. In humans, there is increasing evidence that the host's cytokine response is genetically determined and that the genetic variability of cytokines underlies the complexity of interindividual differences in the immune response to micro organism invasions. We review the influence of host cytokine gene on the susceptibility to and the severity of parasitic, bacterial and viral infections. Proinflammatory cytokine polymorphisms are discussed in detail because of their importance in the course of severe infections such as meningococcal disease, cerebral malaria and septic shock. Genetic variants of the IL-10 gene, an antiinflammatory cytokine appear to be responsible for an uncontrolled and intense CARS and may have also dramatic consequences as an overwhelming inflammatory response. Our greater understanding of the genetic factors that influence mortality and morbidity of infectious diseases will permit identification of genomic markers which may be required for risk stratification of patients targeted for novel immunomodulatory treatments helping clinicians to select the most appropriate treatment options for their patients. |
format | Online Article Text |
id | pubmed-7144473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Kluwer Academic Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-71444732020-04-09 Cytokine Polymorphisms and Susceptibility to Severe Infectious Diseases Chiche, Jean-Daniel Siami, Shidasp Dhainaut, Jean-FrançDois Mira, Jean-Paul Sepsis (Boston) Article Cytokines are key regulators of the host response to infection, controlling the inflammatory reaction which is an essential component of the defense mechanisms. The major importance of these proteins in the pathogenesis and outcome of infectious diseases has been clearly demonstrated. In humans, there is increasing evidence that the host's cytokine response is genetically determined and that the genetic variability of cytokines underlies the complexity of interindividual differences in the immune response to micro organism invasions. We review the influence of host cytokine gene on the susceptibility to and the severity of parasitic, bacterial and viral infections. Proinflammatory cytokine polymorphisms are discussed in detail because of their importance in the course of severe infections such as meningococcal disease, cerebral malaria and septic shock. Genetic variants of the IL-10 gene, an antiinflammatory cytokine appear to be responsible for an uncontrolled and intense CARS and may have also dramatic consequences as an overwhelming inflammatory response. Our greater understanding of the genetic factors that influence mortality and morbidity of infectious diseases will permit identification of genomic markers which may be required for risk stratification of patients targeted for novel immunomodulatory treatments helping clinicians to select the most appropriate treatment options for their patients. Kluwer Academic Publishers 2001 /pmc/articles/PMC7144473/ /pubmed/32288621 http://dx.doi.org/10.1023/A:1013222407924 Text en © Kluwer Academic Publishers 2001 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Chiche, Jean-Daniel Siami, Shidasp Dhainaut, Jean-FrançDois Mira, Jean-Paul Cytokine Polymorphisms and Susceptibility to Severe Infectious Diseases |
title | Cytokine Polymorphisms and Susceptibility to Severe Infectious Diseases |
title_full | Cytokine Polymorphisms and Susceptibility to Severe Infectious Diseases |
title_fullStr | Cytokine Polymorphisms and Susceptibility to Severe Infectious Diseases |
title_full_unstemmed | Cytokine Polymorphisms and Susceptibility to Severe Infectious Diseases |
title_short | Cytokine Polymorphisms and Susceptibility to Severe Infectious Diseases |
title_sort | cytokine polymorphisms and susceptibility to severe infectious diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144473/ https://www.ncbi.nlm.nih.gov/pubmed/32288621 http://dx.doi.org/10.1023/A:1013222407924 |
work_keys_str_mv | AT chichejeandaniel cytokinepolymorphismsandsusceptibilitytosevereinfectiousdiseases AT siamishidasp cytokinepolymorphismsandsusceptibilitytosevereinfectiousdiseases AT dhainautjeanfrancdois cytokinepolymorphismsandsusceptibilitytosevereinfectiousdiseases AT mirajeanpaul cytokinepolymorphismsandsusceptibilitytosevereinfectiousdiseases |